Firefly Neuroscience (NASDAQ:AIFF – Get Free Report) and CompuGroup Medical SE & Co. KGaA (OTCMKTS:CMPVF – Get Free Report) are both healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, earnings, risk, analyst recommendations, profitability, dividends and valuation.
Insider & Institutional Ownership
5.0% of Firefly Neuroscience shares are held by institutional investors. Comparatively, 24.3% of CompuGroup Medical SE & Co. KGaA shares are held by institutional investors. 6.9% of Firefly Neuroscience shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
Profitability
This table compares Firefly Neuroscience and CompuGroup Medical SE & Co. KGaA’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Firefly Neuroscience | -565.40% | -94.68% | -73.51% |
| CompuGroup Medical SE & Co. KGaA | N/A | N/A | N/A |
Earnings & Valuation
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Firefly Neuroscience | $1.14 million | 14.65 | -$19.88 million | ($0.63) | -1.70 |
| CompuGroup Medical SE & Co. KGaA | N/A | N/A | N/A | C$0.56 | 59.70 |
CompuGroup Medical SE & Co. KGaA has lower revenue, but higher earnings than Firefly Neuroscience. Firefly Neuroscience is trading at a lower price-to-earnings ratio than CompuGroup Medical SE & Co. KGaA, indicating that it is currently the more affordable of the two stocks.
Analyst Recommendations
This is a summary of current recommendations and price targets for Firefly Neuroscience and CompuGroup Medical SE & Co. KGaA, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Firefly Neuroscience | 1 | 0 | 0 | 0 | 1.00 |
| CompuGroup Medical SE & Co. KGaA | 0 | 0 | 0 | 0 | 0.00 |
Summary
CompuGroup Medical SE & Co. KGaA beats Firefly Neuroscience on 6 of the 9 factors compared between the two stocks.
About Firefly Neuroscience
Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. is based in Toronto, Canada.
About CompuGroup Medical SE & Co. KGaA
CompuGroup Medical SE & Co. KGaA provides e-health services worldwide. It operates through Ambulatory Information Systems, Hospital Information Systems, Consumer and Health Management Information Systems, and Pharmacy Information Systems segments. The Ambulatory Information Systems segment develops and sells practice management software for registered physicians, medical care centers, and physician networks; offers supplementary app, internet, and intranet solutions; and delivers solutions for medical facilities, such as medica; care centers and practice associations. The Hospital Information Systems segment develop and sells of clinical and administrative solutions for inpatient sector; provides software solutions for administration, planning and provision of care in outpatient and inpatient medical facilities; and healthcare services to acute care hospitals, rehabilitation centers, welfare institutions, multi-location hospital networks, healthcare regions, regional care organizations, medical laboratories, and radiologists. The Consumer and Health Management Information Systems segment provides software interfaces for data exchange, portals for retrieving data from the German outpatient healthcare market, medical decision support tools, medication and treatment databases for healthcare service providers, solutions for the insurance industry, and digital healthcare applications, patient portals, and mobile apps; and operates telematics infrastructure business, that offers secure links, as well as security solutions for service providers. The Pharmacy Information Systems segment develop and sell administrative and billing related software applications, including procuring and shipping, managing and controlling inventory, planning, performing, and monitoring retail activities for pharmacies. The company was founded in 1987 and is headquartered in Koblenz, Germany.
Receive News & Ratings for Firefly Neuroscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Firefly Neuroscience and related companies with MarketBeat.com's FREE daily email newsletter.
